Vitamin D3 for Life

Live Enlightened

Physiology

Vitamin D Receptors in Heart Muscle and Cardiac Remodelling: Study Summary

Previous related pageVitamin D Receptors in Heart Muscle and Cardiac Remodelling: Full StudyNext related pageVitamin D Receptors in Heart Muscle and Cardiac Remodelling: Full Study
Study at a glance

What happens when heart muscle cells lose vitamin D receptors?

Two studies used genetically changed mice to examine vitamin D receptors in heart muscle cells. These receptors are proteins that receive vitamin D signals. The researchers asked whether losing them changes heart structure or pumping. This is different from testing vitamin D supplements or studying a low vitamin D blood result in people.

What happened to mouse hearts in the 2011 study?

The 2011 study found larger heart muscle cells and thicker heart walls after receptor loss. It did not demonstrate worse pumping on the tests used or more scar tissue. Measured blood pressure was lower rather than higher. A separate experiment in newborn rat heart cells suggested a possible cell-growth mechanism, but did not prove that this mechanism explained the whole effect.

How did mouse hearts respond to stress in the 2024 study?

The 2024 study used different genetics and surgery that made the heart pump against greater pressure. It did not find the same abnormal pattern before this stress. Afterwards, mice lacking the receptors had worse ultrasound measures of pumping, but similar muscle-cell enlargement and measured scarring. Other tests of contraction and relaxation did not show the same difference. Gene-activity findings based on one heart section per group were exploratory, not proof of extra scar tissue.

Do these mouse findings show a treatment benefit in people?

Vitamin D receptor signals can matter in these mouse models, but the result depends on the experiment and what is measured. Heart enlargement, scarring and reduced pumping are separate findings. Small studies using different designs do not establish one rule for every setting. Neither study shows a treatment benefit in people or defines a vitamin D supplement dose or blood target.

Read the full article below ↓

Vitamin D receptors in heart muscle may influence how the heart responds to stress, but mouse studies do not all show the same outcome. Chen and colleagues’ 2011 experiment found enlarged muscle after receptor deletion without a demonstrated decline in the assessed pumping function. A later experiment found a different balance between structure and function. For the detailed methods, results and comparison, read Vitamin D Receptors in Heart Muscle and Cardiac Remodelling: Full Study.

What the researchers tested

A cardiomyocyte is a heart muscle cell. Chen’s team used genetic engineering to remove functional vitamin D receptors from these cells in approximately six-month-old mice. The question was whether receptor loss within the muscle could affect cardiac growth, rather than whether supplements benefited people.

The main comparison used mice sharing a background in which one vitamin D receptor gene copy was already inactive throughout the body. The remaining targeted copy was deleted in the cardiomyocytes of the experimental group. The researchers examined baseline animals and animals receiving seven days of isoproterenol, a drug used experimentally to stimulate cardiac growth.

What the 2011 study found

Left ventricular weight relative to body weight averaged 2.69 mg/g in baseline controls and 3.16 mg/g in the receptor-deletion group. With isoproterenol, the corresponding values were 3.27 and 3.78 mg/g. The results table reports 8-12 mice per group. Microscopy showed larger muscle cells, and ultrasound showed thicker ventricular walls.

These were structural findings. The investigators did not find increased interstitial fibrosis, and they reported no significant genotype difference in the assessed systolic or diastolic function. Ejection fraction, the proportion of the filled chamber volume expelled in a beat, was similar. A larger heart muscle therefore should not be described as demonstrated pump failure in this experiment.

Calcium and parathyroid hormone measurements did not show the major disturbances found in whole-body receptor knockouts. Measured diastolic and mean arterial pressure were lower in the heart-cell knockout mice, making increased measured blood pressure an unlikely simple explanation for their enlargement.

A possible signalling mechanism

The enlarged hearts had increased modulatory calcineurin inhibitory protein 1 (MCIP1), a protein associated with a signalling pathway involving the calcineurin enzyme and gene-regulating NFAT proteins. In a separate experiment using newborn rat heart cells, active vitamin D partially reduced isoproterenol-induced MCIP1 RNA, protein and promoter activity.

The two findings make this pathway a plausible contributor. They do not establish that it is the only mechanism or prove that supplementing adult humans would reverse the changes. The cultured-cell experiment was not a treatment trial in the adult knockout mice.

Why the later study matters

In 2024, Zupcic and colleagues used a different genetic construction and four weeks of pressure overload caused by narrowing the aorta. Their male mice did not show the earlier study’s abnormal baseline phenotype. After pressure overload, both genotypes had similar muscle-cell enlargement and measured fibrosis, but the knockout animals had worse ultrasound measures of pumping. There were five mice in each pressure-overload group for those ultrasound comparisons.

Other measurements did not all separate the groups: catheter-based contraction and relaxation indices showed no corresponding genotype difference. An exploratory RNA-mapping analysis suggested stronger inflammatory and fibrosis-related signalling, but it compared only one heart section per genotype. Molecular signals associated with fibrosis were not proof of greater deposited scar tissue.

What this means for readers

The studies use different genetics and different stressors, so their results cannot be reduced to a single rule that receptor loss always enlarges the heart. They contribute to understanding vitamin D and heart physiology by separating local receptor biology, structural remodelling and measured function.

Neither study defines a supplement dose, a blood target or a demonstrated treatment benefit in people. Vitamin D status and vitamin D effect are different questions: removing a receptor is not equivalent to observing a low blood concentration. The appropriate conclusion is that cardiac receptor signalling deserves investigation within clearly specified models, while human treatment claims require human intervention evidence.

Scientific sources

Chen S, Law CS, Grigsby CL, Olsen K, Hong TT, Zhang Y, Yeghiazarians Y, Gardner DG. Cardiomyocyte-Specific Deletion of the Vitamin D Receptor Gene Results in Cardiac Hypertrophy. Circulation. 2011;124(17):1838-1847. DOI: 10.1161/CIRCULATIONAHA.111.032680. PMID: 21947295. The principal experiment; supplementary methods and echocardiography are part of this publication.

Zupcic A, Latic N, Oubounyt M, Ramesova A, Carmeliet G, Baumbach J, Elkjaer ML, Erben RG. Ablation of Vitamin D Signaling in Cardiomyocytes Leads to Functional Impairment and Stimulation of Pro-Inflammatory and Pro-Fibrotic Gene Regulatory Networks in a Left Ventricular Hypertrophy Model in Mice. International Journal of Molecular Sciences. 2024;25(11):5929. DOI: 10.3390/ijms25115929. PMID: 38892126. A separate mouse experiment used here to assess the consistency and limits of the earlier findings.

Related reading

Original sources

Source

Cardiomyocyte-Specific Deletion of the Vitamin D Receptor Gene Results in Cardiac Hypertrophy

Published in Circulation (2011).

Publication details

Chen S, Law CS, Grigsby CL, Olsen K, Hong TT, Zhang Y, Yeghiazarians Y, Gardner DG. Cardiomyocyte-Specific Deletion of the Vitamin D Receptor Gene Results in Cardiac Hypertrophy. Circulation. 2011;124(17):1838-1847. DOI: 10.1161/CIRCULATIONAHA.111.032680. PMID: 21947295. The principal experiment; supplementary methods and echocardiography are part of this publication.

Read more →
Source

Ablation of Vitamin D Signaling in Cardiomyocytes Leads to Functional Impairment and Stimulation of Pro-Inflammatory and Pro-Fibrotic Gene Regulatory Networks in a Left Ventricular Hypertrophy Model in Mice

This study aimed to further elucidate the role of vitamin D signaling in the development of left ventricular (LV) hypertrophy and dysfunction.

Publication details

Zupcic A, Latic N, Oubounyt M, Ramesova A, Carmeliet G, Baumbach J, Elkjaer ML, Erben RG. Ablation of Vitamin D Signaling in Cardiomyocytes Leads to Functional Impairment and Stimulation of Pro-Inflammatory and Pro-Fibrotic Gene Regulatory Networks in a Left Ventricular Hypertrophy Model in Mice. International Journal of Molecular Sciences. 2024;25(11):5929. DOI: 10.3390/ijms25115929. PMID: 38892126. A separate mouse experiment used here to assess the consistency and limits of the earlier findings.

Read more →